Cerebrolysin Use in Patients with Liver Damage—A Translational Study
Cerebrolysin Use in Patients with Liver Damage—A Translational Study
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
The treatment of acute life-threatening events in patients suffering from chronic pathologies is problematic, as physicians need to consider multisystemic drug effects. Regarding Cerebrolysin, a Sonic Hedgehog signaling pathway amplifier and one of the few approved neurotrophic treatments for stroke patients, concerns of excessive Hedgehog pathway...
Alternative Titles
Full title
Cerebrolysin Use in Patients with Liver Damage—A Translational Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9b1ef24514a84fd5b3f58af1edbcb678
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b1ef24514a84fd5b3f58af1edbcb678
Other Identifiers
ISSN
2075-1729
E-ISSN
2075-1729
DOI
10.3390/life12111791
